-
Something wrong with this record ?
Small intestinal bacterial overgrowth syndrome
J. Bures, J. Cyrany, D. Kohoutova, M. Förstl, S. Rejchrt, J. Kvetina, V. Vorisek, M. Kopacova,
Language English Country Taiwan
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
NLK
Free Medical Journals
from 1998
Freely Accessible Science Journals
from 1998
PubMed Central
from 1997
Europe PubMed Central
from 1997
- MeSH
- Breath Tests MeSH
- Diagnosis, Differential MeSH
- Humans MeSH
- Prognosis MeSH
- Blind Loop Syndrome epidemiology etiology physiopathology therapy MeSH
- Intestine, Small microbiology pathology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Human intestinal microbiota create a complex polymicrobial ecology. This is characterised by its high population density, wide diversity and complexity of interaction. Any dysbalance of this complex intestinal microbiome, both qualitative and quantitative, might have serious health consequence for a macro-organism, including small intestinal bacterial overgrowth syndrome (SIBO). SIBO is defined as an increase in the number and/or alteration in the type of bacteria in the upper gastrointestinal tract. There are several endogenous defence mechanisms for preventing bacterial overgrowth: gastric acid secretion, intestinal motility, intact ileo-caecal valve, immunoglobulins within intestinal secretion and bacteriostatic properties of pancreatic and biliary secretion. Aetiology of SIBO is usually complex, associated with disorders of protective antibacterial mechanisms (e.g. achlorhydria, pancreatic exocrine insufficiency, immunodeficiency syndromes), anatomical abnormalities (e.g. small intestinal obstruction, diverticula, fistulae, surgical blind loop, previous ileo-caecal resections) and/or motility disorders (e.g. scleroderma, autonomic neuropathy in diabetes mellitus, post-radiation enteropathy, small intestinal pseudo-obstruction). In some patients more than one factor may be involved. Symptoms related to SIBO are bloating, diarrhoea, malabsorption, weight loss and malnutrition. The gold standard for diagnosing SIBO is still microbial investigation of jejunal aspirates. Non-invasive hydrogen and methane breath tests are most commonly used for the diagnosis of SIBO using glucose or lactulose. Therapy for SIBO must be complex, addressing all causes, symptoms and complications, and fully individualised. It should include treatment of the underlying disease, nutritional support and cyclical gastro-intestinal selective antibiotics. Prognosis is usually serious, determined mostly by the underlying disease that led to SIBO.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025635
- 003
- CZ-PrNML
- 005
- 20120918124441.0
- 007
- ta
- 008
- 120817s2010 ch f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.3748/wjg.v16.i24.2978 $2 doi
- 035 __
- $a (PubMed)20572300
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ch
- 100 1_
- $a Bureš, Jan, $d 1954- $7 nlk19990073060 $u 2nd Department of Medicine, Charles University in Praha, Faculty of Medicine at Hradec Kralove, University Teaching Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. bures@lfhk.cuni.cz
- 245 10
- $a Small intestinal bacterial overgrowth syndrome / $c J. Bures, J. Cyrany, D. Kohoutova, M. Förstl, S. Rejchrt, J. Kvetina, V. Vorisek, M. Kopacova,
- 520 9_
- $a Human intestinal microbiota create a complex polymicrobial ecology. This is characterised by its high population density, wide diversity and complexity of interaction. Any dysbalance of this complex intestinal microbiome, both qualitative and quantitative, might have serious health consequence for a macro-organism, including small intestinal bacterial overgrowth syndrome (SIBO). SIBO is defined as an increase in the number and/or alteration in the type of bacteria in the upper gastrointestinal tract. There are several endogenous defence mechanisms for preventing bacterial overgrowth: gastric acid secretion, intestinal motility, intact ileo-caecal valve, immunoglobulins within intestinal secretion and bacteriostatic properties of pancreatic and biliary secretion. Aetiology of SIBO is usually complex, associated with disorders of protective antibacterial mechanisms (e.g. achlorhydria, pancreatic exocrine insufficiency, immunodeficiency syndromes), anatomical abnormalities (e.g. small intestinal obstruction, diverticula, fistulae, surgical blind loop, previous ileo-caecal resections) and/or motility disorders (e.g. scleroderma, autonomic neuropathy in diabetes mellitus, post-radiation enteropathy, small intestinal pseudo-obstruction). In some patients more than one factor may be involved. Symptoms related to SIBO are bloating, diarrhoea, malabsorption, weight loss and malnutrition. The gold standard for diagnosing SIBO is still microbial investigation of jejunal aspirates. Non-invasive hydrogen and methane breath tests are most commonly used for the diagnosis of SIBO using glucose or lactulose. Therapy for SIBO must be complex, addressing all causes, symptoms and complications, and fully individualised. It should include treatment of the underlying disease, nutritional support and cyclical gastro-intestinal selective antibiotics. Prognosis is usually serious, determined mostly by the underlying disease that led to SIBO.
- 650 _2
- $a syndrom slepé kličky $x epidemiologie $x etiologie $x patofyziologie $x terapie $7 D001765
- 650 _2
- $a dechové testy $7 D001944
- 650 _2
- $a diferenciální diagnóza $7 D003937
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a tenké střevo $x mikrobiologie $x patologie $7 D007421
- 650 _2
- $a prognóza $7 D011379
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Cyrany, Jiří $7 xx0165194
- 700 1_
- $a Kohoutová, Darina. $7 mzk2013797579
- 700 1_
- $a Förstl, Miroslav, $d 1971-2011 $7 mzk2003192172
- 700 1_
- $a Rejchrt, Stanislav, $d 1963- $7 mzk2005306779
- 700 1_
- $a Květina, Jaroslav
- 700 1_
- $a Vorisek, Viktor
- 700 1_
- $a Kopáčová, Marcela $7 xx0032944
- 773 0_
- $w MED00006918 $t World journal of gastroenterology : WJG $x 1007-9327 $g Roč. 16, č. 24 (2010), s. 2978-90
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20572300 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20120918124622 $b ABA008
- 999 __
- $a ok $b bmc $g 947677 $s 782981
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 16 $c 24 $d 2978-90 $i 1007-9327 $m World journal of gastroenterology $n World J Gastroenterol $x MED00006918
- LZP __
- $a Pubmed-20120817/10/03